Single-Fraction Stereotactic Body Radiation Therapy: A Paradigm During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond?
Author:
Publisher
Elsevier BV
Subject
Radiology Nuclear Medicine and imaging,Oncology
Reference125 articles.
1. Schrag D, Hershman DL, Basch E. Oncology practice during the COVID-19 pandemic [e-pub ahead of print]. JAMA. https://doi.org/10.1001/jama.2020.6236. Accessed April 5, 2020.
2. Ning MS, McAleer MF, Jeter MD, et al. Mitigating the Impact of COVID-19 on oncology: Clinical and operational lessons from a prospective radiation oncology cohort tested for COVID-19 [e-pub ahead of print]. Radiother Oncol. https://doi.org/10.1016/j.radonc.2020.05.037. Accessed April 5, 2020.
3. Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China;Liang;Lancet Oncol,2020
4. Coronavirus: Older persons with cancer in Italy in the COVID-19 pandemic;Fratino;Front Oncol,2020
5. Mehta V, Goel S, Kabarriti R, et al. Case fatality rate of cancer patients with COVID-19 in a New York hospital system [e-pub ahead of print]. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-20-0516. Accessed April 5, 2020.
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Long-Term Survival and Failure Outcomes of Single-Fraction Stereotactic Body Radiation Therapy in Early Stage NSCLC;JTO Clinical and Research Reports;2023-12
2. Nursing Care for Metastatic Bone Cancer: Trends for the Future;International Journal of Environmental Research and Public Health;2023-07-31
3. Long-Term Outcomes of TROG 13.01 SAFRON II Randomized Trial of Single- Versus Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases;Journal of Clinical Oncology;2023-07-01
4. Stereotactic Body Radiotherapy for the Management of Early-Stage Non–Small-Cell Lung Cancer: A Clinical Overview;JCO Oncology Practice;2023-05
5. Is single fraction the future of stereotactic body radiation therapy (SBRT)? A critical appraisal of the current literature;Clinical and Translational Radiation Oncology;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3